Privia Health Group (PRVA) Stock Forecast & Price Target

$18.75

-0.69 (-3.55%)

(As of 09/20/2024 08:54 PM ET)

Privia Health Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 15 Analyst Ratings

Based on 15 Wall Street analysts who have issued ratings for Privia Health Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for PRVA.

Consensus Price Target

$24.86
32.57% Upside

High Forecast	$30.00
Average Forecast	$24.86
Low Forecast	$19.00

According to the 15 analysts' twelve-month price targets for Privia Health Group, the average price target is $24.86. The highest price target for PRVA is $30.00, while the lowest price target for PRVA is $19.00. The average price target represents a forecasted upside of 32.57% from the current price of $18.75.

Type	Current Forecast 9/24/23 to 9/23/24	1 Month Ago 8/25/23 to 8/24/24	3 Months Ago 6/26/23 to 6/25/24	1 Year Ago 9/24/22 to 9/24/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$24.86	$24.79	$24.92	$36.86
Forecasted Upside	32.57% Upside	29.25% Upside	27.53% Upside	37.64% Upside

Get Privia Health Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.

Forget Trump and Kamala (Ad)

I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.

THIS CALENDAR is the only thing that matters for you and your financial health right now.

PRVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PRVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Privia Health Group Stock vs. The Competition

Type	Privia Health Group	Medical Companies	S&P 500
Consensus Rating Score	2.93	2.77	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	32.57% Upside	2,890.97% Upside	7.41% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/26/2024	Robert W. Baird 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$23.00 ➝ $24.00	+15.05%
8/14/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$28.00 ➝ $28.00	+44.26%
7/9/2024	Evercore ISI 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$23.00 ➝ $20.00	+18.69%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/20/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$22.00 ➝ $19.00	+14.53%
5/15/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$28.00 ➝ $24.00	+34.30%
Get the Latest News and Ratings for PRVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.
5/10/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$37.00 ➝ $26.00	+44.36%
5/1/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$28.00 ➝ $24.00	+30.43%
4/22/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$25.00	+38.27%
3/6/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$38.00 ➝ $30.00	+41.38%
3/1/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$31.00 ➝ $29.00	+31.28%
3/1/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$30.00 ➝ $26.00	+16.49%
2/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$33.00 ➝ $25.00	+25.63%
2/22/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$27.00 ➝ $21.00	+2.79%
12/6/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$27.00	+29.19%
5/5/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$39.00 ➝ $40.00	+38.70%
4/11/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$33.00	+17.61%
3/7/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$41.00	+44.26%
2/3/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$32.00	+15.52%
1/9/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$45.00 ➝ $40.00	+85.96%
11/17/2022	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$42.00	+77.97%
11/11/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$46.00 ➝ $39.00	+36.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:24 AM ET.

PRVA Forecast - Frequently Asked Questions

What is Privia Health Group's forecast for 2024?: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Privia Health Group is $24.86, with a high forecast of $30.00 and a low forecast of $19.00.
Should I buy or sell Privia Health Group stock right now?: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 2 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PRVA shares.
Does Privia Health Group's stock price have much upside?: According to analysts, Privia Health Group's stock has a predicted upside of 27.51% based on their 12-month stock forecasts.
What analysts cover Privia Health Group?: Privia Health Group has been rated by research analysts at Evercore ISI, Robert W. Baird, and Royal Bank of Canada in the past 90 days.
Do Wall Street analysts like Privia Health Group more than its competitors?: Analysts like Privia Health Group more than other "medical" companies. The consensus rating score for Privia Health Group is 2.93 while the average consensus rating score for "medical" companies is 2.77. Learn more on how PRVA compares to other companies.